15 Einträge gefunden

1. Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer - results from the HER-OS patient registry

   1. Witzel, Isabell
   2. Müller, Volkmar
   3. Abenhardt, Wolfgang
   4. Kaufmann, Manfred
   5. Schoenegg, Winfried
   6. Schneeweis, Andreas
   7. Jänicke, Fritz

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
2. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

   1. Witzel, Isabell
   2. Milde-Langosch, Karin
   3. Schmidt, Marcus
   4. Karn, Thomas
   5. Becker, Sven
   6. Wirtz, Ralph
   7. Rody, Achim

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
3. Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers

   1. Witzel, Isabell
   2. Graeser, Monika
   3. Karn, Thomas
   4. Schmidt, Markus
   5. Wirtz, Ralph
   6. Schütze, Dina
   7. Rausch, Alma

   2013 - Forschungsinformationssystem des UKE
4. Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer

   1. Schütze, Dina
   2. Milde-Langosch, Karin
   3. Witzel, Isabell
   4. Rody, Achim
   5. Karn, Thomas
   6. Schmidt, Marcus
   7. Choschzick, Matthias

   2013 - Forschungsinformationssystem des UKE
5. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.

   1. Witzel, Isabell
   2. Schröder, Christine
   3. Müller, Volkmar
   4. Zander, Hilke
   5. Tachezy, Michael
   6. Henningsen, Maike
   7. Jänicke, Fritz

   2012 - Forschungsinformationssystem des UKE
6. Management of patients with brain metastases receiving trastuzumab treatment for metastatic breast cancer.

   1. Witzel, Isabell
   2. Kantelhardt, Eva Johanna
   3. Milde-Langosch, Karin
   4. Henningsen, Maike
   5. Zeitz, Julia
   6. Harbeck, Nadia
   7. Jänicke, Fritz

   2011 - Forschungsinformationssystem des UKE
7. Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.

   1. Schröder, Christine
   2. Witzel, Isabell
   3. Müller, Volkmar
   4. Krenkel, Sylke
   5. Wirtz, Ralph M
   6. Jänicke, Fritz
   7. Schumacher, Udo

   2011 - Forschungsinformationssystem des UKE
8. Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin

   1. Henningsen, Maike
   2. Kilic, Ergin
   3. Koehler, Nadine
   4. Löning, Thomas
   5. Witzel, Isabell
   6. Hagel, Christian
   7. Höller, Sylvia

   2011 - Forschungsinformationssystem des UKE
9. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

   1. Witzel, Isabell
   2. Milde-Langosch, Karin
   3. Wirtz, Ralph M
   4. Roth, Claudia
   5. Henningsen, Maike
   6. Mahner, Sven
   7. Zu Eulenburg, Christine Gräfin

   2010 - Forschungsinformationssystem des UKE
10. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

    1. Henningsen, Maike
    2. Köhler, N
    3. Kersten, Jan Felix
    4. Milde-Langosch, Karin
    5. Beck, K
    6. Höller, S
    7. Müller, Volkmar

    2010 - Forschungsinformationssystem des UKE - frei zugänglich
11. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.

    1. Henningsen, Maike
    2. Müller, Volkmar
    3. Wirtz, R M
    4. Schröder, Christine
    5. Krenkel, S
    6. Witzel, Isabell
    7. Lisboa, B W

    2008 - Forschungsinformationssystem des UKE
12. Trastuzumab in pregnancy associated with poor fetal outcome.

    1. Witzel, Isabell
    2. Müller, Volkmar
    3. Harps, E
    4. Jänicke, Fritz
    5. De Wit, Maike

    2008 - Forschungsinformationssystem des UKE
13. Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer.

    1. Witzel, Isabell
    2. Thomssen, C
    3. Krenkel, S
    4. Wilczak, Waldemar
    5. Bubenheim, M
    6. Pantel, K
    7. Neumann, R

    2006 - Forschungsinformationssystem des UKE
14. Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.

    1. Müller, Volkmar
    2. Witzel, Isabell
    3. Pantel, Klaus
    4. Krenkel, Sylke
    5. Lück, Hans Joachim
    6. Neumann, Rainer
    7. Keller, Thomas

    2006 - Forschungsinformationssystem des UKE
15. Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

    1. Müller, Volkmar
    2. Witzel, Isabell
    3. Lück, Hans Joachim
    4. Köhler, Günter
    5. von Minckwitz, Gunther
    6. Möbus, Volker
    7. Sattler, Daniel

    2004 - Forschungsinformationssystem des UKE